Cure Kids Ventures

What is Cure Kids Ventures?

Cure Kids Ventures (CKV) is a New Zealand-based venture capital fund that specializes in seed and early-stage investments, with a focus on healthcare and biotechnology sectors. Operating since 2008, the fund is dedicated to supporting emerging healthcare companies that have the potential to significantly improve child health outcomes.

It is owned by the Cure Kids Foundation, which is recognized as New Zealand's largest private funder of child health research. CKV's expertise and interests span a wide range of healthcare-related fields, including medical devices, medications, diagnostics, health information systems, and healthcare delivery systems. They are well-known for their deep connections within the New Zealand healthcare industry, leveraging relationships with universities, research institutes, and various organisations that emerge from over four decades of private research funding.

This extensive network enhances CKV's ability to source and secure promising investment opportunities. CKV's team possesses global experience and a mix of skills crucial for nurturing early-stage companies.

Their experience covers areas such as intellectual property commercialization, global business growth, science, finance, and mergers and acquisitions. CKV's reputation as an informed and value-added investor stems from not only providing financial resources but also offering investee companies access to industry-specific expertise and networks. Cure Kids Ventures places strategic emphasis on finding and cultivating companies that align with their vision of ensuring a healthy childhood for all.

They have demonstrated an enduring commitment to the sector with the recent launch of their third investment fund, continuing a tradition of investing in healthcare innovations. CKV’s role within the Cure Kids ecosystem is fundamental, underpinning the broader vision of the foundation and its objectives.